SOLACI-CACI 2024 Call for Papers Is Now Open. Send Your Work Now

Submit your scientific papers and challenging clinical cases for SOLACI-CACI 2024 Congress, which marks SOLACI’s 30th anniversary!

The best papers and cases will be published in leading indexed PubMed Journals (CRT & MINERVA). Additionally, if your work is selected, your registration fee will be waived!

Year after year, SOLACI Congress receives hundreds of submissions from all corners of Latin America. For this edition, we anticipate great participation of young colleagues and experienced professionals in the region with their abstracts and challenging cases. It will be a high-level academic experience.

The call for papers OPENS on February 2, 2024.

The call for papers ENDS on April 4, 2024.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOL SOLACI performed a new procedure in Argentina using bioabsorbable stents in pulmonary branches

The SOLACI Solidarity Program carried out a new procedure on a patient from the region of Frías, in Santiago del Estero (Argentina), during October...

Venezuela 2025 Sessions | Young Interventional Cardiologists Contest

Call for Case Submissions LIII SOLACI Regional Sessions – 18th Andean Region We invite all young Latin American cardiologists to submit clinically relevant interventional cardiology cases...

See the Best Moments from the Costa Rica 2025 Sessions

Relive the most remarkable highlights of the Costa Rica 2025 Sessions, held from October 8 to 10, 2025, at the Intercontinental Hotel in San...

Data Update Campaign for SOLACI Members. Let’s Stay Connected

Data Update for SOLACI Members. We aim to keep our members informed about all developments and matters related to the association. In this regard, we...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

CALIPSO: Calcified Lesions and Use of OCT

Percutaneous coronary intervention (PCI) in calcified lesions remains one of the most challenging scenarios in daily practice, as these lesions are often accompanied by...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...